MedPath

Examination of the protective efficacy for vein thromboembolism (VTE) and safety of enoxaparin sodium after the abdominal surgery

Not Applicable
Conditions
colon cancer
Registration Number
JPRN-UMIN000009598
Lead Sponsor
Department of Coloproctological Surgery Juntendo University Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) The patient who bleeds 2 thrombocytopenia 3) Patient having the complications that may bleed(including a gastrointestinal ulcer, gastrointestinal diverticulitis, colitis, acute bacterial endocarditis, seriously ill high blood pressure, severe diabetes, the DIC). 4) Patient with impaired severe liver function 5) Sensitivity to danaparoid, heparin, low molecular weight heparin. 6) The patient who has the past of cerebral hemorrhage 7) The patient who received the operation of the central nervous system or ophthalmology within three months before registration of the final examination

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outbreak frequency of symptomatic PTE or VTE judged by imaging study
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath